{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:11:07Z","timestamp":1790989867215,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.cpcardiol.2024.102977","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T11:25:24Z","timestamp":1734521124000},"page":"102977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pathophysiology and management of postural orthostatic tachycardia syndrome (POTS): A literature review"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0427-3826","authenticated-orcid":false,"given":"Mohamad","family":"Ghazal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Rahman","family":"Akkawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Fancher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Oundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hammad","family":"Tanzeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiba","family":"Sajjad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5740-9670","authenticated-orcid":false,"given":"Alexandros","family":"Briasoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102977_bib0001","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/joim.12852","article-title":"Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management","volume":"285","author":"Fedorowski","year":"2019","journal-title":"J Intern Med"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102977_bib0002","first-page":"108","article-title":"Adolescent fatigue, POTS, and recovery: a guide for clinicians","volume":"44","author":"Kizilbash","year":"2014","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"14","key":"10.1016\/j.cpcardiol.2024.102977_bib0003","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1177\/0883073820948679","article-title":"Treatment of postural orthostatic tachycardia syndrome with medication: a systematic review","volume":"35","author":"Hasan","year":"2020","journal-title":"J Child Neurol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102977_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000585","article-title":"Syndromes of orthostatic intolerance and syncope in young adults","volume":"4","author":"Hamrefors","year":"2017","journal-title":"Open Heart"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102977_bib0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pcad.2020.03.010","article-title":"Postural orthostatic tachycardia syndrome (POTS): a critical assessment","volume":"63","author":"Olshansky","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"issue":"23","key":"10.1016\/j.cpcardiol.2024.102977_bib0006","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1161\/CIRCULATIONAHA.112.144501","article-title":"Postural tachycardia syndrome (POTS)","volume":"127","author":"Raj","year":"2013","journal-title":"Circulation"},{"issue":"4 Suppl 5","key":"10.1016\/j.cpcardiol.2024.102977_bib0007","first-page":"S19","article-title":"Postural tachycardia syndrome (POTS)","volume":"45","author":"Low","year":"1995","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102977_bib0008","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0025-6196(11)61027-6","article-title":"Postural orthostatic tachycardia syndrome: the Mayo clinic experience","volume":"82","author":"Thieben","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10.1016\/j.cpcardiol.2024.102977_bib0009","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4065\/74.11.1106","article-title":"Postural tachycardia syndrome: clinical features and follow-up study","volume":"74","author":"Sandroni","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"22","key":"10.1016\/j.cpcardiol.2024.102977_bib0010","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.vaccine.2015.03.098","article-title":"Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus","volume":"33","author":"Brinth","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.cpcardiol.2024.102977_bib0011","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12026-016-8855-1","article-title":"Postural tachycardia syndrome (POTS) with anti-NMDA receptor antibodies after human papillomavirus vaccination","volume":"65","author":"Blitshteyn","year":"2017","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102977_bib0012","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/ene.12272","article-title":"Postural tachycardia syndrome following human papillomavirus vaccination","volume":"21","author":"Blitshteyn","year":"2014","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102977_bib0013","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0009922817728701","article-title":"Autoimmunity, autonomic neuropathy, and the HPV vaccination: a vulnerable subpopulation","volume":"57","author":"Schofield","year":"2018","journal-title":"Clin Pediatr (Phila)"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102977_bib0014","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrneurol.2011.187","article-title":"Postural tachycardia syndrome\u2014Current experience and concepts","volume":"8","author":"Mathias","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102977_bib0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/0961203316629558","article-title":"Postural orthostatic tachycardia syndrome (POTS)\u2014A novel member of the autoimmune family","volume":"25","author":"Dahan","year":"2016","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102977_bib0016","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cjca.2019.12.024","article-title":"Canadian cardiovascular society position statement on postural orthostatic tachycardia syndrome (POTS) and related disorders of chronic orthostatic intolerance","volume":"36","author":"Raj","year":"2020","journal-title":"Can J Cardiol"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102977_bib0017","first-page":"e60","article-title":"2017 ACC\/AHA\/HRS Guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"136","author":"Shen","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102977_bib0018","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1673","article-title":"Pediatric disorders of orthostatic intolerance","volume":"141","author":"Stewart","year":"2018","journal-title":"Pediatrics"},{"issue":"1-2","key":"10.1016\/j.cpcardiol.2024.102977_bib0019","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.autneu.2011.02.004","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"161","author":"Freeman","year":"2011","journal-title":"Auton Neurosci"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102977_bib0020","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.hrthm.2015.03.029","article-title":"2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope","volume":"12","author":"Sheldon","year":"2015","journal-title":"Heart Rhythm"},{"issue":"21","key":"10.1016\/j.cpcardiol.2024.102977_bib0021","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/eurheartj\/ehy037","article-title":"2018 ESC guidelines for the diagnosis and management of syncope","volume":"39","author":"Brignole","year":"2018","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102977_bib0022","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11910-015-0583-8","article-title":"Postural tachycardia syndrome: beyond orthostatic intolerance","volume":"15","author":"Garland","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102977_bib0023","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004127","article-title":"Postural tachycardia syndrome is associated with significant symptoms and functional impairment predominantly affecting young women: a UK perspective","volume":"4","author":"McDonald","year":"2014","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102977_bib0024","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1017\/S1047951117002888","article-title":"Demographics of a large paediatric postural orthostatic tachycardia syndrome program","volume":"28","author":"Boris","year":"2018","journal-title":"Cardiol Young"},{"issue":"33","key":"10.1016\/j.cpcardiol.2024.102977_bib0025","first-page":"1","article-title":"A profile of patients with postural tachycardia syndrome and their experience of healthcare in the UK","volume":"23","author":"Kavi","year":"2016","journal-title":"Br J Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102977_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/VHRM.S127393","article-title":"Postural tachycardia syndrome: current perspectives","volume":"14","author":"Wells","year":"2018","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.cpcardiol.2024.102977_bib0027","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.autneu.2018.04.008","article-title":"Pharmacotherapy for postural tachycardia syndrome","volume":"215","author":"Miller","year":"2018","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.cpcardiol.2024.102977_bib0028","doi-asserted-by":"crossref","unstructured":"Cheshire, WP, Jr., Syncope. Continuum (Minneap Minn), 2017. 23(2, Selected Topics in Outpatient Neurology): p. 335-358.","DOI":"10.1212\/CON.0000000000000444"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102977_bib0029","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1152\/jappl.1991.70.2.523","article-title":"Initial blood pressure fall on stand up and exercise explained by changes in total peripheral resistance","volume":"70","author":"Sprangers","year":"1991","journal-title":"J Appl Physiol (1985)"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102977_bib0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1509723","article-title":"Baroreflex dysfunction","volume":"382","author":"Kaufmann","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102977_bib0031","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1475-097X.1996.tb00565.x","article-title":"Cardiac output and blood pressure during active and passive standing","volume":"16","author":"Tanaka","year":"1996","journal-title":"Clin Physiol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102977_bib0032","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/cs0670321","article-title":"Mechanisms of initial blood pressure response to postural change","volume":"67","author":"Borst","year":"1984","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102977_bib0033","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41598-023-50886-8","article-title":"Symptom presentation by phenotype of postural orthostatic tachycardia syndrome","volume":"14","author":"Angeli","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102977_bib0034","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1540-8167.2005.00318.x","article-title":"The Postural tachycardia syndrome: a concise guide to diagnosis and management","volume":"17","author":"Grubb","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102977_bib0035","doi-asserted-by":"crossref","first-page":"655","DOI":"10.12998\/wjcc.v3.i7.655","article-title":"Reversible postural orthostatic tachycardia syndrome","volume":"3","author":"Abdulla","year":"2015","journal-title":"World J Clin Cases"},{"issue":"14","key":"10.1016\/j.cpcardiol.2024.102977_bib0036","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1056\/NEJM200010053431404","article-title":"The neuropathic postural tachycardia syndrome","volume":"343","author":"Jacob","year":"2000","journal-title":"New Engl J Med"},{"issue":"8","key":"10.1016\/j.cpcardiol.2024.102977_bib0037","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1212\/01.wnl.0000267663.05398.40","article-title":"The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome","volume":"69","author":"Garland","year":"2007","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.cpcardiol.2024.102977_bib0038","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-245012","article-title":"Improvement of hyperadrenergic postural orthostatic tachycardia syndrome (POTS) with methylated B vitamins in the setting of a heterozygous COMT Val158Met polymorphism","volume":"14","author":"Mittal","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.cpcardiol.2024.102977_bib0039","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fphys.2014.00220","article-title":"Neuronal and hormonal perturbations in postural tachycardia syndrome","volume":"5","author":"Mar","year":"2014","journal-title":"Front Physiol"},{"issue":"13","key":"10.1016\/j.cpcardiol.2024.102977_bib0040","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/01.CIR.0000160356.97313.5D","article-title":"Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome","volume":"111","author":"Raj","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102977_bib0041","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/CS20050254","article-title":"Increased plasma angiotensin II in postural tachycardia syndrome (POTS) is related to reduced blood flow and blood volume","volume":"110","author":"Stewart","year":"2006","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102977_bib0042","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/HYPERTENSIONAHA.110.151787","article-title":"Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome","volume":"56","author":"Fu","year":"2010","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102977_bib0043","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.hrthm.2010.11.009","article-title":"Abnormalities of angiotensin regulation in postural tachycardia syndrome","volume":"8","author":"Mustafa","year":"2011","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102977_bib0044","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/HYPERTENSIONAHA.106.076216","article-title":"Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure?","volume":"50","author":"Chappell","year":"2007","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102977_bib0045","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.peptides.2011.05.012","article-title":"New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine\/intracellular angiotensin II","volume":"32","author":"Zhuo","year":"2011","journal-title":"Peptides,"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102977_bib0046","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.108.127357","article-title":"Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome","volume":"53","author":"Stewart","year":"2009","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102977_bib0047","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.hrthm.2012.05.002","article-title":"Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome","volume":"9","author":"Coffin","year":"2012","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102977_bib0048","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/01.CIR.96.2.575","article-title":"Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia","volume":"96","author":"Jacob","year":"1997","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102977_bib0049","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1097\/MJT.0000000000000468","article-title":"Droxidopa in the treatment of postural orthostatic tachycardia syndrome","volume":"24","author":"Ruzieh","year":"2017","journal-title":"Am J Ther"},{"issue":"14","key":"10.1016\/j.cpcardiol.2024.102977_bib0050","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1212\/WNL.0b013e31826d5f95","article-title":"Deconditioning in patients with orthostatic intolerance","volume":"79","author":"Parsaik","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.cpcardiol.2024.102977_bib0051","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.autneu.2018.04.005","article-title":"Autoimmunity in postural orthostatic tachycardia syndrome: current understanding","volume":"215","author":"Vernino","year":"2018","journal-title":"Auton Neurosci"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102977_bib0052","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1017\/S1047951120000165","article-title":"Family history of associated disorders in patients with postural tachycardia syndrome","volume":"30","author":"Boris","year":"2020","journal-title":"Cardiol Young"},{"issue":"12","key":"10.1016\/j.cpcardiol.2024.102977_bib0053","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/MEG.0000000000000740","article-title":"Is there a relationship between gluten sensitivity and postural tachycardia syndrome?","volume":"28","author":"Penny","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"13","key":"10.1016\/j.cpcardiol.2024.102977_bib0054","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1177\/0961203315587566","article-title":"Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS)","volume":"24","author":"Blitshteyn","year":"2015","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102977_bib0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/NRL.0000000000000134","article-title":"Spectrum of autonomic nervous system impairment in Sj\u00f6gren syndrome","volume":"22","author":"Goodman","year":"2017","journal-title":"Neurologist"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102977_bib0056","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/rheumatology\/keh132","article-title":"Neurally mediated hypotension in systemic lupus erythematosus patients with fibromyalgia","volume":"43","author":"Tang","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cpcardiol.2024.102977_bib0057","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-221405","article-title":"Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment","volume":"2018","author":"Weinstock","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102977_bib0058","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/europace\/euw154","article-title":"Antiadrenergic autoimmunity in postural tachycardia syndrome","volume":"19","author":"Fedorowski","year":"2017","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102977_bib0059","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000755","article-title":"Autoimmune basis for postural tachycardia syndrome","volume":"3","author":"Li","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"11-12","key":"10.1016\/j.cpcardiol.2024.102977_bib0060","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/prca.201200049","article-title":"Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndrome","volume":"6","author":"Wang","year":"2012","journal-title":"Proteomics Clin Appl"},{"issue":"12","key":"10.1016\/j.cpcardiol.2024.102977_bib0061","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM200009213431204","article-title":"Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies","volume":"343","author":"Vernino","year":"2000","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.cpcardiol.2024.102977_bib0062","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1212\/01.wnl.0000312280.44805.5d","article-title":"Invited article: autonomic ganglia: target and novel therapeutic tool","volume":"70","author":"Vernino","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102977_bib0063","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000395","article-title":"Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome","volume":"2","author":"Green","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102977_bib0064","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1540-8167.2008.01407.x","article-title":"Postural tachycardia syndrome (POTS)","volume":"20","author":"Low","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102977_bib0065","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1152\/japplphysiol.00367.2014","article-title":"Acute volume loading and exercise capacity in postural tachycardia syndrome","volume":"117","author":"Figueroa","year":"2014","journal-title":"J Appl Physiol (1985)"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102977_bib0066","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02291387","article-title":"Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome","volume":"10","author":"Gordon","year":"2000","journal-title":"Clin Auton Res"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102977_bib0067","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00246-015-1274-6","article-title":"Intravenous hydration for management of medication-resistant orthostatic intolerance in the adolescent and young adult","volume":"37","author":"Moak","year":"2016","journal-title":"Pediatr Cardiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102977_bib0068","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s10286-008-0487-7","article-title":"POTS versus deconditioning: the same or different?","volume":"18","author":"Joyner","year":"2008","journal-title":"Clin Auton Res"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102977_bib0069","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10286-010-0091-5","article-title":"Effects of exercise training on arterial-cardiac baroreflex function in POTS","volume":"21","author":"Galbreath","year":"2011","journal-title":"Clin Auton Res"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102977_bib0070","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.hrthm.2015.12.012","article-title":"The international POTS registry: evaluating the efficacy of an exercise training intervention in a community setting","volume":"13","author":"George","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cpcardiol.2024.102977_bib0071","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.autneu.2018.07.001","article-title":"Exercise and non-pharmacological treatment of POTS","volume":"215","author":"Fu","year":"2018","journal-title":"Auton Neurosci"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102977_bib0072","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1017\/S1047951116002559","article-title":"Recent advances in the understanding of the mechanisms underlying postural tachycardia syndrome in children: practical implications for treatment","volume":"27","author":"Zheng","year":"2017","journal-title":"Cardiol Young"},{"issue":"8","key":"10.1016\/j.cpcardiol.2024.102977_bib0073","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.mayocp.2018.01.025","article-title":"Efficacy of therapies for postural tachycardia syndrome: a systematic review and meta-analysis","volume":"93","author":"Wells","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cpcardiol.2024.102977_bib0074","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fped.2019.00460","article-title":"Efficacy of \u03b2-blockers on postural tachycardia syndrome in children and adolescents: a systematic review and meta-analysis","volume":"7","author":"Deng","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.cpcardiol.2024.102977_bib0075","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3389\/fnins.2019.01214","article-title":"Heart rate variability predicts therapeutic response to metoprolol in children with postural tachycardia syndrome","volume":"13","author":"Wang","year":"2019","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102977_bib0076","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1253\/circj.CJ-10-0514","article-title":"Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome","volume":"75","author":"Chen","year":"2011","journal-title":"Circ J"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102977_bib0077","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s13311-018-0612-9","article-title":"Efficacy of propranolol, bisoprolol, and pyridostigmine for postural tachycardia syndrome: a randomized clinical trial","volume":"15","author":"Moon","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"S1","key":"10.1016\/j.cpcardiol.2024.102977_bib0078","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.24.1_supplement.977.1","article-title":"Chronic treatment with propranolol does not alter sympathetic and cardiovagal baroreflex sensitivity in the postural orthostatic tachycardia syndrome","volume":"24","author":"Fu","year":"2010","journal-title":"The FASEB Journal"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102977_bib0079","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/CIRCULATIONAHA.108.846501","article-title":"Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more","volume":"120","author":"Raj","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102977_bib0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/CS20130222","article-title":"A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome","volume":"126","author":"Ross","year":"2014","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102977_bib0081","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jacc.2012.04.025","article-title":"Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome","volume":"60","author":"Zhang","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102977_bib0082","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jpeds.2013.04.039","article-title":"Postural orthostatic tachycardia syndrome with increased erythrocytic hydrogen sulfide and response to midodrine hydrochloride","volume":"163","author":"Yang","year":"2013","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102977_bib0083","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jpeds.2014.04.032","article-title":"Plasma copeptin and therapeutic effectiveness of midodrine hydrochloride on postural tachycardia syndrome in children","volume":"165","author":"Zhao","year":"2014","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102977_bib0084","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF02281112","article-title":"Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone","volume":"10","author":"Freitas","year":"2000","journal-title":"Clin Auton Res"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102977_bib0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MPG.0000000000000305","article-title":"Effect of fludrocortisone acetate on chronic unexplained nausea and abdominal pain in children with orthostatic intolerance","volume":"59","author":"Fortunato","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102977_bib0086","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jama.285.1.52","article-title":"Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial","volume":"285","author":"Rowe","year":"2001","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102977_bib0087","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2016.04.030","article-title":"Fludrocortisone for the prevention of vasovagal syncope: a randomized, placebo-controlled trial","volume":"68","author":"Sheldon","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102977_bib0088","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1517\/14656566.2011.548321","article-title":"Ivabradine: recent and potential applications in clinical practice","volume":"12","author":"Riccioni","year":"2011","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102977_bib0089","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14779072.2016.1165092","article-title":"Ivabradine for the treatment of chronic heart failure","volume":"14","author":"Henri","year":"2016","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102977_bib0090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40256-016-0178-z","article-title":"Ivabradine: a review of labeled and off-label uses","volume":"16","author":"Oliphant","year":"2016","journal-title":"Am J Cardiovasc Drugs"},{"issue":"suppl_G","key":"10.1016\/j.cpcardiol.2024.102977_bib0091","doi-asserted-by":"crossref","first-page":"G30","DOI":"10.1093\/eurheartj\/suv058","article-title":"Prognostic and symptomatic benefits with ivabradine: lessons from the SHIFT trial","volume":"17","author":"Komajda","year":"2015","journal-title":"European Heart Journal Supplements"},{"issue":"11","key":"10.1016\/j.cpcardiol.2024.102977_bib0092","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/pace.13182","article-title":"Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience","volume":"40","author":"Ruzieh","year":"2017","journal-title":"Pacing Clin Electrophysiol"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102977_bib0093","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacc.2020.12.029","article-title":"Randomized trial of Ivabradine in patients with hyperadrenergic postural orthostatic tachycardia syndrome","volume":"77","author":"Taub","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.cpcardiol.2024.102977_bib0094","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1161\/CIRCULATIONAHA.104.497594","article-title":"Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome","volume":"111","author":"Raj","year":"2005","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102977_bib0095","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1540-8159.2011.03047.x","article-title":"Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience","volume":"34","author":"Kanjwal","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"issue":"2 Suppl","key":"10.1016\/j.cpcardiol.2024.102977_bib0096","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1378\/chest.83.2.436","article-title":"Effects of long-term clonidine administration on the hemodynamic and neuroendocrine postural responses of patients with dysautonomia","volume":"83","author":"Gaffney","year":"1983","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2024.102977_bib0097","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-med-041818-011630","article-title":"Postural orthostatic tachycardia syndrome: mechanisms and new therapies","volume":"71","author":"Mar","year":"2020","journal-title":"Annu Rev Med"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102977_bib0098","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0002-9343(99)80230-7","article-title":"Treatment of orthostatic tachycardia with erythropoietin","volume":"99","author":"Hoeldtke","year":"1995","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102977_bib0099","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/MJT.0b013e3181ef621a","article-title":"Erythropoietin in the treatment of postural orthostatic tachycardia syndrome","volume":"19","author":"Kanjwal","year":"2012","journal-title":"Am J Ther"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102977_bib0100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00415-022-11344-z","article-title":"Immunotherapy with subcutaneous immunoglobulin or plasmapheresis in patients with postural orthostatic tachycardia syndrome (POTS)","volume":"270","author":"Kesterson","year":"2023","journal-title":"J Neurol"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624006121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624006121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T09:23:57Z","timestamp":1745832237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280624006121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0146280624006121"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102977","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiology and management of postural orthostatic tachycardia syndrome (POTS): A literature review","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102977","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102977"}}